DE69934108D1 - Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B - Google Patents

Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B

Info

Publication number
DE69934108D1
DE69934108D1 DE69934108T DE69934108T DE69934108D1 DE 69934108 D1 DE69934108 D1 DE 69934108D1 DE 69934108 T DE69934108 T DE 69934108T DE 69934108 T DE69934108 T DE 69934108T DE 69934108 D1 DE69934108 D1 DE 69934108D1
Authority
DE
Germany
Prior art keywords
hepatitis
vaccines against
combined vaccines
combined
against hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934108T
Other languages
English (en)
Other versions
DE69934108T2 (de
Inventor
Claude Artois
J Clark
Clothilde Thiriart
Gabriel Thoelen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Application granted granted Critical
Publication of DE69934108D1 publication Critical patent/DE69934108D1/de
Publication of DE69934108T2 publication Critical patent/DE69934108T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69934108T 1998-05-01 1999-04-27 Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B Expired - Lifetime DE69934108T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9809507 1998-05-01
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition
PCT/EP1999/003024 WO1999056772A2 (en) 1998-05-01 1999-04-27 Hepatitis vaccine

Publications (2)

Publication Number Publication Date
DE69934108D1 true DE69934108D1 (de) 2007-01-04
DE69934108T2 DE69934108T2 (de) 2007-04-19

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934108T Expired - Lifetime DE69934108T2 (de) 1998-05-01 1999-04-27 Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B

Country Status (29)

Country Link
EP (1) EP1073462B1 (de)
JP (2) JP5138843B2 (de)
KR (1) KR100612547B1 (de)
CN (1) CN1263509C (de)
AR (1) AR016987A1 (de)
AT (1) ATE345815T1 (de)
AU (1) AU743759B2 (de)
BR (1) BR9910157A (de)
CA (1) CA2331086C (de)
CO (1) CO5050367A1 (de)
CY (1) CY1107322T1 (de)
CZ (1) CZ301232B6 (de)
DE (1) DE69934108T2 (de)
DK (1) DK1073462T3 (de)
ES (1) ES2277437T3 (de)
GB (1) GB9809507D0 (de)
GC (1) GC0000101A (de)
HK (1) HK1034202A1 (de)
HU (1) HU228209B1 (de)
IL (1) IL139269A0 (de)
MY (1) MY128929A (de)
NO (1) NO20005483L (de)
NZ (1) NZ507902A (de)
PL (1) PL190729B1 (de)
PT (1) PT1073462E (de)
TR (1) TR200003235T2 (de)
TW (1) TW553744B (de)
WO (1) WO1999056772A2 (de)
ZA (1) ZA200006118B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
DK0835663T3 (da) * 1992-05-23 2010-02-01 Glaxosmithkline Biolog Sa Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
WO1997035612A1 (fr) * 1996-03-23 1997-10-02 The Research Foundation For Microbial Diseases Of Osaka University Antigene a fragment fonctionnel de la toxine du tetanos, et vaccin contre le tetanos

Also Published As

Publication number Publication date
MY128929A (en) 2007-02-28
ATE345815T1 (de) 2006-12-15
CZ301232B6 (cs) 2009-12-16
CA2331086C (en) 2010-06-22
NZ507902A (en) 2002-03-28
KR20010043224A (ko) 2001-05-25
HUP0101652A1 (hu) 2001-09-28
PT1073462E (pt) 2007-01-31
CY1107322T1 (el) 2012-11-21
TW553744B (en) 2003-09-21
PL344137A1 (en) 2001-10-08
DK1073462T3 (da) 2007-02-26
DE69934108T2 (de) 2007-04-19
AR016987A1 (es) 2001-08-01
GB9809507D0 (en) 1998-07-01
ZA200006118B (en) 2002-01-30
AU4137999A (en) 1999-11-23
EP1073462B1 (de) 2006-11-22
AU743759B2 (en) 2002-02-07
TR200003235T2 (tr) 2001-03-21
CN1308547A (zh) 2001-08-15
NO20005483D0 (no) 2000-10-31
IL139269A0 (en) 2001-11-25
GC0000101A (en) 2005-06-29
NO20005483L (no) 2000-12-08
JP2002513771A (ja) 2002-05-14
HU228209B1 (en) 2013-01-28
WO1999056772A2 (en) 1999-11-11
JP5138843B2 (ja) 2013-02-06
CO5050367A1 (es) 2001-06-27
BR9910157A (pt) 2001-01-09
CA2331086A1 (en) 1999-11-11
WO1999056772A3 (en) 2000-02-03
ES2277437T3 (es) 2007-07-01
EP1073462A2 (de) 2001-02-07
PL190729B1 (pl) 2005-12-30
HUP0101652A3 (en) 2004-10-28
CZ20004061A3 (cs) 2001-04-11
KR100612547B1 (ko) 2006-08-11
JP2010209118A (ja) 2010-09-24
HK1034202A1 (en) 2001-10-19
CN1263509C (zh) 2006-07-12

Similar Documents

Publication Publication Date Title
DE69932709D1 (de) Hib/dtpa impfstoff und herstellungsmethoden
DE60027440D1 (de) Impfstoff gegen hbv und hpv
DE50112013D1 (de) Deodorantien und antiperspirantien
ATE357252T1 (de) Adjuvanzsysteme und impfstoffe
NO20003303L (no) Vaksine
ATE209045T1 (de) Hepatitis b impfstoff
ID26599A (id) Turunan triazola dan imidazola
DE60021260D1 (de) Wassergetragene vulkanisierbare fluorgummimischungen und damit beschichteter gegenstand
AR028343A1 (es) Derivados de pirrolidina y piperidina
ID28721A (id) Bidang luncur dan pinston untuk mesin pembakaran dalam
DE60001107D1 (de) Sichere und handliche hinweisanordung
DE50100186D1 (de) Boiler und Dampfgargerät mit einem derartigen Boiler
DE60029075D1 (de) Kopiergerät und Kopierverfahren
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
DE60223540D1 (de) Mundschutz und mundschutzfolie
DE69934108D1 (de) Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
NO20024617D0 (no) Aryl- og heteroarylsulfonater
ATE333894T1 (de) Vakzine gegen infektiöse bursitis
DE60022990D1 (de) Markierungsfolie und verbundmarkierungsfolie
DK1105498T3 (da) HIV vaccine
SI1073462T1 (sl) Kombinirano cepivo proti hepatitisu A in hepatitisu B

Legal Events

Date Code Title Description
8364 No opposition during term of opposition